Aggregator
Dissecting the genetic and proteomic risk factors for delirium
Clonal hematopoiesis in apparent treatment-resistant hypertension, insights from multiple medical centers and community-based cohorts
Targeting RhoA nuclear mechanoactivity rejuvenates aged hematopoietic stem cells
Author Correction: Loss of MFE-2 impairs microglial lipid homeostasis and drives neuroinflammation in Alzheimer’s pathogenesis
A ten-year drive to credit authors for their work — and why there’s still more to do
Putting nature on the balance sheet: how to account for the ecological costs of our actions
What is the future of intelligence? The answer could lie in the story of its evolution
The Internet is broken and the inventor of the World Wide Web wants to fix it
Chasing crayfish and the leeches that live on them
Hydrogen fuel isn’t always the green choice
NIH shake-up to grant decision-making sparks concern over political meddling
Policy drops “paylines” based on peer-review scores and requires geography and other factors to guide approvals
Popular obesity drug fails in hotly anticipated Alzheimer’s trials
The studies may still hold clues to the powers and limits of GLP-1 drugs
New vapor tool fights mosquitoes by slowly releasing insecticide in homes. Will it catch on?
World Health Organization supports “spatial repellents” to prevent malaria, but it’s unclear who will pay for them
The muscle-brain axis in type 2 diabetes: Molecular pathways linking sarcopenia and cognitive decline
Type 2 diabetes mellitus (T2DM) is increasingly recognized as a shared pathological substrate for both sarcopenia and cognitive decline, particularly Alzheimer's disease (AD). This review synthesizes current evidence on the converging molecular pathways linking insulin resistance, hyperglycaemia, mitochondrial dysfunction, oxidative stress, and chronic inflammation to muscle wasting and neurodegeneration. Central to this interplay is the muscle-brain axis, a bidirectional communication network...
Blood biomarkers of Alzheimer's disease and progression across different stages of cognitive decline in the community
Blood biomarkers of Alzheimer's disease (AD) are promising for dementia prediction, but their association with progression across intermediate stages of cognitive decline in the general population remains unclear. We followed 2148 dementia-free individuals from a Swedish population-based cohort for up to 16 years. Associations between baseline AD blood biomarkers and transitions between normal cognition, mild cognitive impairment (MCI), and dementia were examined. Lower amyloid-β42/40 ratio and...
The Muscle-Brain Axis in Type 2 Diabetes: Molecular Pathways Linking Sarcopenia and Cognitive Decline
Type 2 diabetes mellitus (T2DM) is increasingly recognized as a shared pathological substrate for both sarcopenia and cognitive decline, particularly Alzheimer's disease (AD). This review synthesizes current evidence on the converging molecular pathways linking insulin resistance, hyperglycaemia, mitochondrial dysfunction, oxidative stress, and chronic inflammation to muscle wasting and neurodegeneration. Central to this interplay is the muscle-brain axis, a bidirectional communication network...
Disruption of Krox20-Notch1 signaling blocks meibomian gland development and homeostasis leading to dry eye disease
Meibomian gland dysfunction (MGD) is the leading cause of Dry Eye Disease (DED), accounting for approximately 90% of DED cases worldwide. The transcription factor KROX20 has been shown to mark stem cells that play a critical role in Meibomian gland (MG) development and homeostasis, however, the molecular mechanisms underlying these processes are not well understood. In this report, we used multiple Krox20 lineage tracing and ablation studies to investigate lineage commitment during MG...
Cognition and brain network connectivity in timed up & go performance
Gait performance depends on numerous aspects of brain functioning that are also relevant to key cognitive processes throughout the lifespan. The Timed Up and Go (TUG) test has been shown to be a reliable tool for assessing age-related mobility changes and risk of falls in older adults. This study aimed to predict TUG performance using motor-cognitive inter-network connectivity, cognitive performance and socio-demographics. 189 participants without cognitive impairment were included. Mobility was...
Pathological tau alters head direction signaling and induces spatial disorientation
Spatial disorientation is emerging as an early cognitive biomarker of dementia, but the underlying neural mechanisms remain undefined. The anterodorsal nucleus of the thalamus (ADn) exhibits early and selective vulnerability to pathological misfolded forms of tau, a major hallmark of Alzheimer's disease. As the ADn contains a high density of head direction (HD) cells, we hypothesized that ptau disrupts HD cell activity, promoting spatial disorientation. To test this, we virally expressed human...
Mechanisms governing poly(A)-tail-length specificity of the human PAN2-PAN3 deadenylase complex
The lifespan of most eukaryotic mRNAs is modulated by the gradual shortening of the poly(A) tail and removal of the associated poly(A)-binding protein. The human PAN2-PAN3 complex catalyzes initial deadenylation by shortening long poly(A) tails associated with PABPC1. Both PAN2-PAN3 and PABPC1 are evolutionarily conserved from fungi to humans. How the human complex has adapted to recognize and act on longer poly(A) tails characteristic of mammalian mRNAs remains unclear. Here, we report a method...